[{"Assets_0_FY_USD":295699000.0,"CommonStockSharesOutstanding_0_FY_shares":36516075.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-95342000.0,"NetIncomeLoss_1_FY_USD":-35906000.0,"NetIncomeLoss_4_FY_USD":-120587000.0,"StockholdersEquity_0_FY_USD":268845000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180302"}]